ACC: FDA Announces Review of ACCORD Data
(medpagetoday.co) ATLANTA (MedPage Today) -- The FDA said it will conduct a full review of findings from a study which concluded that neither aggressive lipid-lowering therapy nor tight blood pressure control reduced cardiovascular events in persons with diabetes.